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SUMMARY
Identification of covariates associated with disease is a key part of epidemiological research.
Yet, while adjustment for imperfect diagnostic accuracy is well established when estimating
disease prevalence, similar adjustment when estimating covariate effects is far less common,
although of important practical relevance due to the sensitivity of such analyses to
misclassification error. Case-study data exploring evidence for seasonal differences in Salmonella
prevalence using serological testing is presented, in addition simulated data with known
properties are analysed. It is demonstrated that : (i) adjusting for misclassification error in models
comprising continuous covariates can have a very substantial impact on the resulting conclusions
which can then be drawn from any analyses ; and (ii) incorporating prior knowledge through
Bayesian estimation can provide potentially more informative assessments of covariates while
removing the assumption of perfect diagnostic accuracy. The method presented is widely
applicable and easily generalized to many types of epidemiological studies.
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INTRODUCTION
A primary objective of many epidemiological studies
is to test hypothesized relationships, for example
between specific covariates of interest and some re-
sponse variable, denoting say the presence of, or ex-
posure to, a pathogen or parasite [1–5]. If, however,
the method of diagnosis used to classify subjects as
disease positive (negative) suffers from imperfect sen-
sitivity and/or specificity then the observed response
variable is an estimate of the diagnosis positive frac-
tion of subjects in the study population – typically
referred to as apparent prevalence. In contrast, what
is actually desired is an estimate of the disease positive
fraction – the true prevalence. Moreover, analyses
of diseases which have low prevalence represent a
particular challenge because even when using a diag-
nostic with very high specificity, false positives may be
more numerous than true positives.
A complication in performing any data analyses is
that the true prevalence in a study with an imperfect
diagnostic is not directly observed, but rather con-
tained latently within the data collected. The analytical
challenge for the epidemiologist is to release this latent
information, and thus enable estimation of the effects
of the covariates of interest, after adjusting for diag-
nostic misclassification. Analytical approaches for
misclassification in regression models in epidemiology
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were introduced some years ago [6–8] ; however, the
use of such approaches is far from common practice.
It is intuitively obvious that additional uncertainty
must be introduced into any analyses when an im-
perfect rather than gold-standard test is used, and
thus a resulting reduction in statistical power. What
may be surprising in practice is just how large an im-
pact this may have on the conclusions which can then
be drawn from any analyses. This is the key message
of this article, i.e. that misclassification error, can and
should, always be investigated to ensure scientifically
credible conclusions of regression analyses involving
imperfect diagnostics. The impact of an imperfect di-
agnostic is first examined using simulated data, fol-
lowed by analyses which explore temporal (seasonal)
fluctuations in Salmonella prevalence in farmed pigs.
Salmonella is zoonotic, and one of the main risks from
this pathogen to humans is through the consumption
of pork products which accounts for up to 20% of
human salmonellosis cases found in some European
countries, and it remains the second highest (regard-
ing occurrence) in the list of human zoonotic diseases
across the European Union [9–12]. Frequentist and
Bayesian estimations are both considered and viewed
as complementary approaches.
There exists an extensive literature on the study and
development of methods for analysing results from
imperfect diagnostic tests, both from frequentist and
Bayesian perspectives [13–17]. Adopting a no-gold
standard (NGS) approach does, however, come with
numerous caveats [15], and unlike many other stat-
istical estimation methods the results of model fitting
are not generally testable against the observed data, as
the variables being estimated are latent. It is, however,
very difficult to argue that an NGS approach should
not at least be considered whenever study results are
based on a diagnostic which is not known to be a
gold-standard test against the specific study popu-
lation. This is particularly relevant in analyses focused
on estimation of the effect of covariates, particularly
continuous covariates, as the true functional re-
lationship between the response variable and covari-
ates is generally unknown and hence needs to be
estimated from the observed data. Any additional
variance in the response variable due to mis-
classification error may considerably affect the accu-
racy with which any functional form can be estimated,
with the danger of attributing erroneous covariates to
a particular disease status.
Model identifiability, i.e. are there sufficient degrees
of freedom available given a particular study design to
estimate latent variables, is a particular challenge in
analyses concerned with imperfect diagnostic testing
[18]. In theory, it is highly desirable that a model is
identifiable as otherwise some parameters may be en-
tirely redundant, in which case they should arguably
be removed from any model. For example, in a bi-
nomial distribution it is possible to formulate the
parameter p, the probability of observing a subject
with disease as p=Sep+(1xSp)(1xp), where Se and
Sp are the sensitivity and specificity of the diagnostic
test used, respectively, and p the true disease preva-
lence within the population. The terms p and p here
are the apparent prevalence and true prevalence, re-
spectively. The goodness of fit to observed data will
only depend on the value of p, and no matter what
combination of values are chosen for Se, Sp, p they
cannot improve the goodness of fit to the data, and
hence cannot be uniquely estimated.
Much of the existing methodological NGS litera-
ture focuses on the problem of prevalence estimation
using multiple imperfect tests applied to single or
multiple study populations to ensure model identifia-
bility [13]. In practice, however, it may be that for a
model to be identifiable biologically untenable as-
sumptions may be required, which is, at least in part, a
practical reason for choosing a Bayesian estimation
approach where identifiability is much less of a con-
cern as prior information can be used to avoid this
issue. For epidemiological studies which utilize only a
single diagnostic test, which is common particularly in
larger scale studies, estimation of the latent preva-
lence of disease is still possible but requires alternative
approaches [5, 19].
In terms of previous methodological approaches
to misclassification in regression models, log-linear
analyses where information on error rates is provided
through the availability of supplementary infor-
mation, and logistic regression approaches with ex-
amples using discrete covariates have been available
for many years [6, 7, 20]. However, the uptake of
such approaches in practice has been very limited with
a paucity of studies, particularly temporal and/or
spatial studies which are a key aspect of zoonotic
epidemiological research [21].
This article describes how to estimate the effects of
covariates in relation to the unobserved ‘true ’ preva-
lence in a population when an imperfect diagnostic
test is used, and explores the resulting impact on the
precision of the parameters of interest. In the analyses
presented, the simplest case of a single continuous
covariate is considered which is both sufficient for
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illustrative purposes, and also epidemiologically rel-
evant in a zoonotic context as demonstrated in the
later section Salmonella case study. Models with both
continuous and discrete covariates and using multiple
imperfect tests are deferred to the Discussion. Of
related interest is using frequentist and Bayesian
estimations as complementary approaches, with the
former assisting with issues of parameter stability and
robustness, while the latter allows for the incorpor-
ation of valuable prior information which can be used
to decrease variance/increase power.
METHODS
While Bayesian approaches to imperfect diagnostic
test estimation are widespread [22], and increasingly
accessible through software which implements ef-
ficient Markov chain Monte Carlo (MCMC) esti-
mation such as WinBUGS and JAGS [23], a
maximum-likelihood (ML) approach is considered
alongside Bayesian estimation. An advantage of using
ML estimation is that issues and difficulties around
model identifiability are, generally speaking, more
immediately recognizable compared to a Bayesian
approach where the influence of the prior information
used can be sufficient to mask a model which would be
unidentifiable given the observed data alone. This is
practically relevant because if a model is unidentifi-
able in a ML context, then in a Bayesian analyses –
while WinBUGS/JAGS will probably have no
problem in producing parameter estimates – any
results may be very highly sensitive to the prior in-
formation used (e.g. from expert opinion) which may
be undesirable.
Latent variable logistic regression
A binomial regression model with a logit link function
between the latent true prevalence and covariates as-
sociated with disease occurrence can be defined as
follows; for covariate pattern i,
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with qi the probability that a subject with the ith
covariate pattern tests positive (apparent prevalence)
and pi the probability that a subject with the ith co-
variate pattern is disease positive (true prevalence),
where the latter is parameterized as a function of
covariates b. The transposed vector xi
T represents the
ith row of the design matrix X, i.e. the combination of
model parameters which will be used to estimate the
ith covariate pattern. The parameters Se and Sp are,
respectively, the sensitivity and specificity of the di-
agnostic used. When Se=1 and Sp=1 then the model
reverts to the classical logistic regression model where
qi=pi (note that when Se<1 or Sp<1 then qi does not
have a logit link function).
The key aspect in fitting the model in equation (1) to
data is the complication that the pis are latent para-
meters. The expectation maximization (EM) algor-
ithm is a standard approach for ML estimation in the
presence of unobserved variables [15, 24]. Technical
implementation details of an EM algorithm for a la-
tent variable logistic regression model can be found in
the Supplementary material (available online) along
with suitable R code. Model fits were assessed both
visually against the data and also more formally using
the ML ratio test and Akaike’s Information Criterion
(AIC) metric.
Later, Bayesian estimation is applied to the same
form of model using MCMC via JAGS and all com-
puter code is again provided as Supplementary ma-
terial to allow easy replication of the results presented.
As is good practice in Bayesian analyses a large
number of different chains were run from many dif-
ferent initial starting points and of different lengths,
including some very long runs of many millions of
iterations. Trace plots for individual parameters and
deviances were compared and examined to identify
signs of poor behaviour such as very slow mixing, and
also to assess convergence along with the use of the
usual Gelman & Rubin convergence diagnostic [25].
Simulated data
Analysing simulated data where the true parameters
are known with certainty provides a means of in-
vestigating the behaviour and utility of latent variable
approaches. We consider the case of a single covariate
where the logit of the (mean) true prevalence is mod-
elled by a straight line where xi
T comprises of (1, x1,i),
and bT=(b0, b1), hence logit(pi)=b0+x1,ib1. In the
simulated data b0=x2, b1=10 with x1,i taking 24
equally spaced values from 0.2 to 0.4 and Se=0.7 and
Sp=0.9. The simulated data were created in a
straightforward fashion by first generating the (linear
and deterministic) mean on a logit scale, inverting
to the probability scale (i.e. true prevalence pi), then
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creating an apparent probability (qi) for each covari-
ate pattern. Finally, Bernoulli observations were
generated, e.g. coin tosses where ‘heads’ and ‘tails ’
are replaced with diagnosis positive or diagnostic
negative, where qi is the probability of observing a
diagnosis positive observation at covariate pattern i.
Of primary interest is exploring the impact of
allowing additional variance into the regression re-
lationship as a result of diagnostic test error. To this
end two different sample sizes were considered, first
with n=100 independent Bernoulli observations for
each covariate pattern, e.g. for each value of x1,i, and
then a larger dataset with n=2000 Bernoulli ob-
servations per covariate pattern. This gives a total
of 2400 and 48000 individual diagnostic test results,
respectively. These are deliberately large sample
sizes – if the impact of misclassification error is ap-
preciable in such relatively large sample sizes then it is
reasonable to expect this to be larger in smaller data-
sets. Moreover, while 2400 test results might be large
relative to certain types of human epidemiological
studies, this is small relative to data collection in cer-
tain zoonotic contexts, e.g. the later Salmonella case
study in farmed pigs has over 8000 observations, and
in general food safety and meat inspection data can
comprise very large numbers of observations. Each
simulated dataset provides a potential maximum of
24 degrees of freedom (D.F.) and fitting a standard
logistic regression model (where Se=Sp=1) requires
2 D.F. For the latent variable model to be identifiable
it requires that the data contain sufficient additional
information to also allow for Se and Sp to be esti-
mated.
Two different sets of prior distributions are con-
sidered when modelling this data, first, where Se and
Sp have independent Beta distributions, specifically
b(1, 1) (equivalent to uniform on 0, 1), and with b0
and b1 having diffuse independent normal priors with
mean zero and variance 1000. Next, the priors for Se
and Sp are made more informative using b(70, 30) and
b(90, 10), respectively, where these have means of 0.7
and 0.9 and roughly equate to a total prior weighting
of 100 Bernoulli observations (in a simple conjugate
model with a binomial density – and equal to about
1.2% of the weight of the observed data).
Model identifiability and parameter estimation
Two aspects are of particular interest, first is the latent
variable model identifiable. Assessing the identifia-
bility of any given model in a formal mathematical
setting is challenging [18] and still largely an open
question. However, this can be assessed relatively
easily empirically. If the algorithm used to estimate
the model parameters produces different estimates,
e.g. starting the algorithm from different starting
points gives different estimates but which have ident-
ical maximum log-likelihood values, then that is
strong evidence that the likelihood is at least in parts
completely flat, and hence the model is not identifi-
able. Note that in practice some allowance may need
to be made for numerical approximation errors in
whatever algorithms are used. Even if the maximal
log-likelihood values are not identical but only very
similar (for different parameter estimates), then a
similar issue exists since this suggests that the stan-
dard errors for at least some of the model parameters
are likely be very large, and therefore give results
which will not be statistically significant.
Assuming a model is identifiable, the second aspect
of particular interest is estimating the uncertainty in
the parameter(s) of interest, in the case of the simu-
lated data given above this is, b1, the covariate as-
sociated with the presence of disease. To estimate
confidence intervals profile likelihood is used [26]
in all (non-Bayesian) analyses presented. Profile
likelihood is a method for estimating confidence
intervals in the presence of ‘nuisance parameters ’,
for example, to estimate a confidence interval for b1
we need to also take into account the uncertainty in
the other unknown parameters in the model, e.g. b0,
Sp, Se.
In the context of estimating a confidence interval
for b1 then b0, Sp, Se can be considered as nuisance
variables, similarly when estimating b0 then b1, Sp, Se
become nuisance variables. We consider confidence
interval estimation for b1. First, we plot the log-
likelihood function for the latent variable logistic re-
gression model over a range of values for b1, where for
each value of b1 the maximum possible value of the
log-likelihood function is used (allowing the nuisance
parameters to take any values in their range) – this
is called the profile likelihood for b1. Figure 1(c, d)
shows profile likelihood functions for b1 constructed
in this way. A (1xa) confidence interval for b1, where
for example a=0.05 gives a 95% confidence interval
(95% CI), is found by drawing a horizontal line at a
value of 05x2d;1xa below the maximum value of the
profile likelihood function where x2d;1xa is the (1xa)
quantile of the x2 probability distribution with d
degrees of freedom. For a confidence interval for a
single parameter then d=1, for a joint confidence
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interval of two parameters then d=2 and so on.
Therefore, a 95% CI for b1 is given by where a hori-
zontal line crosses the profile likelihood function for
b1 at a distance 05x21;095  192 below the maximum
value of this function (Fig. 1c, d). It is also possible to
estimate joint 95% CIs in an analogous fashion, in
the two-parameter case this interval (or region) is now
defined by a horizontal cross-section across a profile
likelihood surface (see Fig. 2).
Salmonella case study data
Data comprising ELISA serological test results for
exposure to Salmonella from 8028 individual finishing
pigs destined for human consumption in the UK were
analysed. Visual inspection of the data suggests con-
siderable seasonal fluctuations in Salmonella preva-
lence, with a strong peak in late summer and rapid
decline during the winter months for the two years
(2008 and 2009) for which data were available.
Salmonella seasonal variation has been observed
before, and is potentially associated with an in-
crease of the proliferation of bacteria in the farm
environment during the warmer months and an in-
crease in Salmonella shedding by infected pigs result-
ing from heat stress [9, 27]. This is directly relevant to
human health as it implies that the risk of Salmonella
in pork products may be greater during the warmer
months, which may have implications for risk assess-
ment strategies designed to minimize Salmonella en-
tering the food chain. A particular question of interest
is whether analyses using standard binomial logistic
regression (assuming the ELISA is a gold-standard
test) support seasonal variation in prevalence, and
what is the impact of removing this unsupported as-
sumption through fitting a latent variable logistic
regression model. Robust estimates of sensitivity and
specificity of the ELISA used when applied to the
relevant UK pig population are unavailable.
RESULTS
Simulated data
Figure 1(a, b) shows the simulated data along
with corresponding fitted trend lines assuming the
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Fig. 1.Analysis of simulated data. (a, b) Raw data with corresponding fitted trend lines assuming the diagnostic test used was
a gold-standard test [apparent prevalence (dashed line), true prevalence (solid line)] as a function of the covariate. As expected
there is considerable difference between apparent and true prevalence. (a) n=100 per covariate pattern, test positive (T+)
and true prevalence (D+) ; (b) n=2000 per covariate pattern. (c, d) Estimates for the slope parameters in panels (a) and (b).
95% confidence intervals (defined as where the horizontal lines cross the profile likelihood) show there is great uncertainty in
the slope when the test is not a gold standard and this is still considerable even for the much larger sample size. (c) n=100 per
covariate pattern; (d) n=2000 per covariate pattern.
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diagnostic test used was a gold-standard test, and the
true prevalence in the population as a function of the
covariate. Figure 1(c, d) contains the profile likeli-
hood for b1 and corresponding confidence intervals
for the effect of this covariate. The latent variable
model is identifiable with a unique solution
of (b0, b1, Se, Sp)=(x1.38, 7.48, 0.76, 0.999 997) with
maximum log-likelihood of x1635.02 for n=100,
and (b0, b1, Se, Sp)=(x2.12, 11.54, 0.68, 0.953) with
maximum log-likelihood of x32657.91 for n=2000.
For the standard regression model the maximum log-
likelihood values are x1635.11 and x32670.38, re-
spectively, for n=100 and n=2000; note that these
are not the same as those in the latent variable model
as Se and Sp are not implicitly contained within
the parametrization of the standard model. While
the ML solutions are unique, the likelihood surface
is relatively flat resulting in comparatively low par-
ameter precision, as can be seen in the wide confidence
intervals for b1 (Fig. 1c, d, Table 1) ; in contrast, 95%
CIs for b1 in the gold-standard model are relatively
very precise. It is instructive to compare results using
Bayesian estimation with the ML results. Table 1
shows 95% CIs for b1 using 2.5% and 97.5% quan-
tiles.
Salmonella case study
Figure 3a shows the observed data – the apparent
prevalence of finishing pigs for Salmonella split by
calendar month, along with the best-fit regression line
using a standard binomial regression model.
Polynomials in month (as a dummy variable 1–12) of
increasing order were considered and both the ML
ratio test and AIC strongly support a cubic relation-
ship as the best-fitting model (AIC for orders 0–4:
5831.861, 5815.318, 5814.606, 5811.872, 5813.813).
Treating the test as a gold standard, and considering
the relatively narrow range of (cubic) trajectories
which fit within the 95% prediction limits for the
conditional mean (Fig. 3a), suggests that the magni-
tude of this change in prevalence is potentially worthy
of further epidemiological investigation.
We now consider instead that the ELISA has not
been shown to be a gold standard against this specific
study population, and moreover, suppose than no
reliable information is available in respect of likely
true and false positive rates against the study popu-
lation. Using ML estimation to fit a cubic polynomial
latent variable model gives the maximum-likelihood
point estimate (MLE) (b0, b1, b2, b3, Se,
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Sp)=(x5.98, 0.0033, 0.12,x0.0091, 0.99, 0.907), the
true prevalence estimate (Fig. 3a) is clearly well
outside the 95% range of trajectories for the gold-
standard equivalent (maximum log-likelihood is
x2901.61, with x2901.94 in the gold-standard
model).
The existing range of gold-standard prevalence
trajectories need to be adjusted to take into account
the implicitly estimated sensitivity and specificity of
the Salmonella ELISA. Figure 3b shows cubic poly-
nomial trajectories where each of these corresponds
uniquely to a point in the joint 95% confidence set
for the sensitivity and specificity (Se, Sp). Once this
additional uncertainty has been included, not only
does the MLE in the standard binomial model appear
strongly biased relative to the ‘true ’ prevalence MLE,
but the additional uncertainty introduced due to
ignorance of likely prior distributions for (Se, Sp) is
so large that in practical terms it is impossible to
draw any substantive conclusions as to the relation-
ship between calendar month and Salmonella preva-
lence.
Table 1. Analysis of simulated data [95% confidence intervals for slope
parameter (b1) by sample size and model type]
Model
n=100 per
covariate pattern
n=2000 per
covariate pattern
ML (Se=Sp=1) (3.64, 6.18) (4.61, 5.21)
ML (SelSpl1) (3.84, 80.10) (8.64, 21.46)
Bayesian prior1 (SelSpl1) (3.95, 54.66) (9.73, 20.19)
Bayesian prior2 (SelSpl1) (3.55, 22.44) (9.52, 14.73)
ML, Maximum-likelihood model.
Prior 1 is b(1, 1) on both Se and Sp ; prior 2 is b(70, 30) and b(90, 10) for Se and Sp,
respectively.
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Fig. 3. (a) Analysis of Salmonella data. There are great differences between true and apparent prevalence. Total sample size of
8028 pigs, apparent prevalence (T+), latent true prevalence (D+). (b) After accounting for the impact of the imperfect test it
is not possible to draw any conclusions as to seasonal changes in true prevalence. Range of trajectories corresponds to the
joint 95% confidence set for Se and Sp.
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Figure 2 shows an estimate of the joint (profile)
likelihood surface for (Se, Sp). The critical value – the
value of the profile likelihood surface at the cross-
section required to produce a joint 95% confidence
set for (Se, Sp) – isx2904.61, and as is clear from the
contour plot that while it is not completely flat, and
hence strictly speaking the model is identifiable, it
is so flat that this results in the very wide range
of trajectories for the monthly prevalence estimates
shown in Figure 3b (the Supplementary online
material contains an additional contour plot with
wider ranges).
Given the very wide range of uncertainty in the ML
estimation it is instructive to investigate how much
this could be reduced by the introduction of prior in-
formation, for example sourced from a smaller scale
study on the same target population whose aim was
estimation of diagnostic accuracy. Figure 4 shows re-
sults from using Bayesian estimation with prior dis-
tributions for Se and Sp of b(99, 1) and b(99, 1),
respectively, with bi for i=0, 1, 2, 3 having diffuse
independent normal priors with mean zero and vari-
ance 1000. These are highly informative priors with
low variance and very high accuracy for both sensi-
tivity and specificity. Not surprisingly, the variance in
trajectories for the true prevalence in the Bayesian
model is extremely smaller than in the ML model
(with unknown Se and Sp), but still rather larger than
the gold-standard ML model (Fig. 4c).
As a practically important footnote, estimating the
Bayesian model required some care. In a Bayesian
analyses the usual objective is to estimate probability
distributions for each parameter of interest (which
can then provide, for example confidence intervals),
which are a combination of the data available and
prior knowledge. The key part of this estimation
process when using WinBUGS/JAGS is that they at-
tempt to describe (e.g. map) a possibly very complex
surface which defines the joint probability distri-
bution for all parameters in the model. They do this
by effectively ‘walking’ around this landscape taking
different sized steps, depending on the specific algor-
ithm used. During this process it is possible to get
‘ trapped’ in a particular area of the surface and
therefore the map of the landscape it produces will be
at best incomplete, if not entirely unreliable. In the
Salmonella analyses many different ‘walks’ (Markov
chains) were performed from different initial starting
points in the landscape, and for varying numbers of
steps which is generally considered good practice in
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Fig. 4. Bayesian estimation of Salmonella data using extremely strong priors of b(99, 1), close to perfect accuracy, for Se and
Sp. There still exists a very large amount of uncertainty in estimates of true prevalence over time and much more than
assuming a gold-standard test. (a) Prior and posterior densities for Se. (b) Prior and posterior densities for Sp. (c) Range of
trajectories corresponding to the top 95% of log-likelihood values sampled during Markov chain estimation of the Bayesian
latent variable model. The trajectory estimate with highest posterior log-likelihood is also shown.
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MCMC analyses. About half of the chains appeared
to get trapped indefinitely sampling around a mode
with log-likelihood of about x2915, whereas other
chains sampled around a mode with log-likelihood of
about x2902, the latter corresponding to the ML
analyses. Some chains eventually reached the ML
mode but some did not even after many millions of
iterations (steps). The ML analyses was valuable in
assessing whether the results from the Bayesian esti-
mation procedure were robust (technical note: chains
sampling from the node atx2915 had values of about
1.0 for the usual Gelman & Rubin convergence diag-
nostic [25] indicating convergence, and similarly for
the chains sampling around the ML node). Summary
outputs and diagnostics can be found in the Sup-
plementary material (online).
DISCUSSION
There are two key results from the analyses presented.
First, that even a relatively small margin of mis-
classification error in the response variable in re-
gression models can considerably increase the
variance of the estimated functional relationship.
Second, the methods presented for adjusting for mis-
classification error in regression models are relatively
straightforward, especially in a Bayesian context via
MCMC, e.g using either WinBUGS or JAGS (JAGS
code is provided with the Supplementary material).
As illustrated with the case study analyses, however,
performing appropriate diagnostics and examining
issues such as sensitivity to priors are then of crucial
importance. The key practical implication of the work
presented is that some form of adjustment for mis-
classification error should be considered in any study
unless there is overwhelming biological evidence that
the diagnostic used is error free.
The methods presented here have particular appli-
cation to the study of rare diseases in populations.
Although highly specific diagnostic tests may be de-
veloped, the specificity is often <1.0. This results in
poor positive predictive values of the tests as the fre-
quency of false positives in the population may exceed
that of true positives. Consequently, there is a sub-
stantial risk of making inappropriate conclusions on
covariates associated with disease presence as they
may be substantially influenced by covariates as-
sociated with individuals who test false positive. For
example a population study of human cystic echino-
coccosis, a highly pathogenic parasitic disease caused
by Echinococus granulosus, in Kazakhstan reported
an estimated prevalence of 0.011 [28]. As part of the
study the population was tested with an ELISA using
cyst fluid antigens isolated from E. granulosus. This
test had a specificity of 0.990 but the positive predic-
tive value was just 0.382. Hence using standard logis-
tic regression to evaluate covariates in the population
associated with infection status, using positive test
results from this ELISA is likely to produce substan-
tial errors.
Only polynomial models in a single continuous
covariate have been considered; however, the methods
demonstrated are equally applicable to richer forms
of regression models, e.g. with more complex variance
structure, and also potentially comprising both con-
tinuous and discrete covariates. Models to identify
temporal or spatial correlations with disease are par-
ticularly obvious candidates. Model identifiability is
again a consideration as this is likely to become more
difficult and challenging the more complex the model
considered for a given dataset (see Supplementary
material for a brief discussion). Also of relevance is
available sample size ; in the simulated data example
the sample sizes used were relatively large, yet the
variance in the regression coefficients was still con-
siderable. This again, suggests that some form of in-
formative prior may be of significant benefit even in
larger studies.
NOTE
Supplementary material accompanies this paper on
the Journal’s website (http://journals.cambridge.org/
hyg).
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